Growth Metrics

Innoviva (INVA) Liabilities and Shareholders Equity (2016 - 2026)

Innoviva filings provide 16 years of Liabilities and Shareholders Equity readings, the most recent being $1.6 billion for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 25.68% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 billion, a 12.48% increase, with the full-year FY2025 number at $1.6 billion, up 25.68% from a year prior.
  • Liabilities and Shareholders Equity hit $1.6 billion in Q4 2025 for Innoviva, up from $1.4 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.6 billion in Q4 2025 to a low of $789.2 million in Q2 2021.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.2 billion (2022), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 49.65% in 2022 and later dropped 10.51% in 2023.
  • Innoviva's Liabilities and Shareholders Equity stood at $926.4 million in 2021, then soared by 32.93% to $1.2 billion in 2022, then grew by 0.98% to $1.2 billion in 2023, then grew by 4.63% to $1.3 billion in 2024, then increased by 25.68% to $1.6 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $1.6 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.3 billion (Q2 2025) per Business Quant data.